Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
hyperthyroidism
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention | Experimental | Patients randomized to intervention will have access to the screening tool |
|
| Control | No Intervention | Patients randomized to control will continue routine practice. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| AI-enabled ECG-based Screening Tool | Other | Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-ECG result was positive or negative. The system will send a message to corresponding physicians if positive finding. |
| Measure | Description | Time Frame |
|---|---|---|
| New-onset hyperthyroidism | A TSH of <0.25 IU/L | Within 30 days |
| New-onset anti-throid drug treatment | New anti-throid drug treatment for patients with subclinical hyperthyroidism | Within 60 days |
| Measure | Description | Time Frame |
|---|---|---|
| All-cause mortality | All-cause mortality | Within 1 year. |
| Cardiac event | Heart failure, arrhythmia, etc. | Within 1 year. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tri-Service General Hospital | Taipei | 114 | Taiwan |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006980 | Hyperthyroidism |
| ID | Term |
|---|---|
| D013959 | Thyroid Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided